Market Research Industry Reports

Insys Therapeutics Inc (INSY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Insys Therapeutics Inc (Insys) is a specialty pharmaceutical company, which discovers, develops and commercializes novel drug delivery systems. The companys flagship product, Subsys is a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients. Its lead product candidate Syndros (dronabinol oral solution) is intendedfor the treatment of chemotherapy-induced nausea and vomiting (CINV) and anorexia associated with weight loss in patients with AIDS. Insys uses its proprietary sublingual spray technology to develop its products. The company offers its products to oncologists, pain specialists and supportive care centers. It has operations in the US and offers its products through third party agreements in international markets. Insys is headquartered in Chandler, Arizona, the US.

Insys Therapeutics Inc (INSY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.




Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Insys Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
Insys Therapeutics Enters into Licensing Agreement with Senzer 11
Insys Therapeutics Enters into Licensing Agreement with Gold Coast Therapeutics 12
Insys Therapeutics Enters into Licensing Agreement with California Pacific Medical Center Research Institute 13
Equity Offering 14
Insys Therapeutics Completes IPO For US$36.8 Million 14
Insys Therapeutics Inc - Key Competitors 16
Insys Therapeutics Inc - Key Employees 17
Insys Therapeutics Inc - Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Mar 08, 2018: INSYS Therapeutics Reports Fourth Quarter and Full Year 2017 Results 19
Nov 02, 2017: INSYS Therapeutics Reports Third Quarter 2017 Results 20
Aug 03, 2017: Insys Therapeutics Reports Second Quarter 2017 Results 21
May 09, 2017: Insys Therapeutics Reports First Quarter 2017 Results 22
Apr 03, 2017: Insys Therapeutics Reports Fourth Quarter and Year End 2016 Results 23
Corporate Communications 25
Apr 02, 2018: INSYS Therapeutics Appoints Trudy Vanhove to Board of Directors 25
Feb 01, 2018: INSYS Therapeutics Appoints Vaseem Mahboob to Board of Directors 26
Oct 29, 2017: INSYS Therapeutics Announces Resignation of Patrick P. Fourteau from Board of Directors 27
Oct 29, 2017: INSYS Therapeutics Founder Dr. John N. Kapoor Steps Down from Board of Directors 28
Jul 18, 2017: Insys Therapeutics Appoints Andrew G. Long as Chief Financial Officer 29
May 16, 2017: Insys Therapeutics Announces Chief Financial Officer Transition 30
May 04, 2017: Insys Therapeutics Appoints Rohit Vishnoi to Board of Directors 31
Apr 24, 2017: Dr. Steven James Joins Insys Therapeutics as Vice President of Medical Affairs 32
Mar 27, 2017: Insys Announces Saeed Motahari to Become President and Chief Executive Officer and Member of the Board of Directors Effective April 17, 2017 33
Jan 09, 2017: Insys Therapeutics Announces Retirement of Dr. John N. Kapoor as CEO and Chairman; Appoints Dr. Santosh Vetticaden as Interim CEO and Steven Meyer as Chairman of the Board 34
Legal and Regulatory 35
Oct 29, 2017: INSYS Therapeutics to Record a Minimum Liability for Department of Justice Settlement in Q3 2017 35
Product News 36
07/31/2017: Insys Announces Availability of SYNDROS, the First and Only FDA-Approved Liquid Dronabinol, by Prescription 36
05/24/2017: Insys Therapeutics Announces FDA Final Product Label for Syndros 37
Product Approvals 38
Dec 06, 2017: FDA Accepts New Drug Application (NDA) for Buprenorphine Sublingual Spray from INSYS Therapeutics 38
Sep 29, 2017: INSYS Therapeutics Files New Drug Application (NDA) for Buprenorphine Sublingual Spray with FDA 39
Mar 23, 2017: DEA Schedules Insys Therapeutics Syndros (dronabinol oral solution) as Schedule II Drug 40
Clinical Trials 41
Dec 07, 2017: INSYS Therapeutics Starts Proof-of-Concept Study of Epinephrine Nasal Spray for Anaphylaxis 41
Other Significant Developments 42
Feb 09, 2018: INSYS Therapeutics Addresses Maryland Attorney Generals Motion 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List Of Tables

List of Tables
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Insys Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Insys Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Insys Therapeutics Enters into Licensing Agreement with Senzer 11
Insys Therapeutics Enters into Licensing Agreement with Gold Coast Therapeutics 12
Insys Therapeutics Enters into Licensing Agreement with California Pacific Medical Center Research Institute 13
Insys Therapeutics Completes IPO For US$36.8 Million 14
Insys Therapeutics Inc, Key Competitors 16
Insys Therapeutics Inc, Key Employees 17
Insys Therapeutics Inc, Other Locations 18
Insys Therapeutics Inc, Subsidiaries 18

List Of Figures

List of Figures
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Insys Therapeutics Inc (INSY) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Insys Therapeutics Inc (Insys) is a specialty pharmaceutical company, which discovers, develops and commercializes novel drug delivery systems of therapeutic compounds. The company harnesses its proprietary sublingual spray technology to

USD 250View Report

Insys Therapeutics Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Insys Therapeutics Inc Company Profile is a detailed strategic and analytical report on Insys Therapeutics Inc. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200View Report

Agile Therapeutics Inc (AGRX) - Medical Equipment - Deals and Alliances Profile

Agile Therapeutics Inc (Agile) is a healthcare company that develops and commercializes prescription contraceptive products for women. The company provides contraceptive patch containing the active ingredients levonorgestrel and ethinyl estradiol

USD 250View Report

C3J Therapeutics Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

C3J Therapeutics Inc (C3J), formerly C3 Jian Inc is a clinical-stage biotechnology company that offers discovery and development of novel targeted antimicrobials, synthetic bacteriophage and antimicrobial peptides. Its pipeline products

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Apr 2018
No. of Pages :43
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube